search reports
Categories
Categories

World Stents Market by Product (coronary, peripheral, and stent-related implants), by Material (Metallic, Polymeric, Natural) – Global Opportunity Analysis and Industry Forecast, 2014-2022

Report Code : li161603
Published Date : 01 August, 2016 | No of Pages: 122

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Companies Mentioned
  • Related Reports
A stent is a metallic or a polymer tube implanted intthe lumen of any blood vessel or a duct in order tkeep the passage open. A variety of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus tallow the passage of food and beverages in patients suffering from esophageal cancer. They are alsinserted in the ureter tprevent obstruction of urine flow from kidney, in the gall bladder tallow passage of bile in patients suffering from gall bladder cancer, and in the abdomen & gastrointestinal tract. They are generally made of metals, polymers, and natural bioabsorbable materials.

The world stent market is estimated tgenerate a revenue of $16,666 million by 2022. The growth in the world stents market is primarily attributed tthe rising geriatric population, whare more susceptible tstrokes and require a stent implant for treatment, technological advancements in stents, increased adoption rate of these devices, and increased risk of restenosis in patients undergoing angioplasty. In addition, unhealthy diet habits and lack of necessary physical activity lead tthe development of cardiovascular diseases, and hence increase the need for percutaneous coronary interventions. Conversely, stringent government regulations for the approval of stents as they are highly specific devices and high cost of stent implant procedures are factors restraining the market growth.

The report segments the world stents market based on product type, material, and geography. Based on product type, it is categorized intcoronary stents and peripheral/vascular stents. Mainly three types of coronary stents are used, namely, drug-eluting stents, bare metal stents, and bioabsorbable stents. Out of these, endothelial progenitor cell capture stent, a type of drug-eluting stent, is preferred over the others as it uses the latest technology and prevents stent thrombosis. Coronary stents was the highest revenue-generating and fastest growing segment in 2015, registering a CAGR of 9.5% during the analysis period, owing tincreasing advances in the field of interventional cardiology coupled with the progress of minimally invasive techniques.

Based on material, the market is segmented intmetallic biomaterials, polymer biomaterials, and natural biomaterials. Among these, metallic stents segment generated the highest revenue in 2015 and natural biomaterials segment is estimated tgrow at fastest CAGR of 10.5% from 2016-2022.

Based on geography, the market is divided intNorth America, Europe, Asia-Pacific, and LAMEA regions. Asia-Pacific is expected tcontinue tdominate due trise in the geriatric population, favorable reimbursement rates, and rise in the prevalence of chronic disorders even among younger population. LAMEA is expected temerge as the area with maximum growth potential, owing tthe presence of high unmet medical needs and constantly improving healthcare infrastructure tcure cardiac disorders, hemodialysis, and other clinical conditions which lead tconstriction of blood vessels. Huge investments in developing nations by key players results in market growth owing tthe rapidly growing aged population.

Key players operating in the world stents market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, STENTYS SA, and TerumCorporation.

1.1 Key benefits

  • The study provides an in-depth analysis of the world stents market with current trends and future estimations telucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 t2022, which is expected tenable the stakeholders tcapitalize on prevailing market opportunities.
  • Extensive analysis by product helps in understanding the various types of devices used for the treatment of chronic diseases and other related cardiac conditions.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • SWOT analysis studies the internal environment of the leading companies for strategy formulation.

1.2 Key market segments

The world stents market is segmented based on product type, material, and geography.

By Type  
Coronary Stents  
Drug-Eluting Stents (DES) 
Bare-Metal Coronary Stents 
Bioabsorbable Stents 
Peripheral Stents  
Iliac  
Femoral-Popliteal 
Renal 
Carotid 
Stent-Related Implants  
Synthetic Grafts 
Vena Cava Filters 
 
By Material
Metallic Biomaterials       
Polymers Biomaterials     
Natural Biomaterials
   
By Region
North America    
U.S.   
Canada   
Mexic  
Europe    
Germany   
U.K.   
France   
Italy
Spain
Rest of Europe   
Asia-Pacific    
Japan   
China   
India
South Korea
Malaysia  
Rest of Asia-Pacific   
LAMEA    
Brazil
South Africa
Egypt
Rest of LAMEA
Chapter: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes

3.4 Market share analysis, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Growing geriatric population and increasing prevalence of chronic diseases
3.5.1.2 Technological advancements in the field of stents
3.5.1.3 Improvement of healthcare infrastructure in developing countries
3.5.1.4 Improved insurance and reimbursement

3.5.2 Restraints

3.5.2.1 High cost of treatment associated with stent implants
3.5.2.2 Stringent approval process for stents

3.5.3 Opportunities

3.5.3.1 Huge market opportunities in the developing countries

Chapter: 4 WORLD STENTS MARKET, BY PRODUCT
4.1 Overview

4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast

4.2 Coronary stents

4.2.1 Market size and forecast
4.2.2 Drug-eluting stents (DES)

4.2.2.1 Market size and forecast

4.2.3 Bare-metal coronary stents

4.2.3.1 Market size and forecast

4.2.4 Bioabsorbable stents

4.2.4.1 Market size and forecast

4.3 Peripheral stents

4.3.1 Market size and forecast
4.3.2 Iliac stents

4.3.2.1 Market size and forecast

4.3.3 Femoral-popliteal stents

4.3.3.1 Market size and forecast

4.3.4 Renal & related stents

4.3.4.1 Market size and forecast

4.3.5 Carotid stents

4.3.5.1 Market size and forecast

4.4 Stent-related implants

4.4.1 Market size and forecast
4.4.2 Synthetic grafts

4.4.2.1 Market size and forecast

4.4.3 Vena cava filters

4.4.3.1 Market size and forecast

Chapter: 5 WORLD STENTS MARKET, BY BIOMATERIAL
5.1 Overview

5.1.1 Market size and forecast

5.2 Metallic biomaterials

5.2.1 Market size and forecast

5.3 Polymeric biomaterials

5.3.1 Market size and forecast

5.4 Natural biomaterials

5.4.1 Market size and forecast

Chapter: 6 WORLD STENTS MARKET, BY GEOGRAPHY, 20142022
6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. market size and forecast
6.2.5 Canada market size and forecast
6.2.6 Mexico market size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany market size and forecast
6.3.5 France market size and forecast
6.3.6 U.K. market size and forecast
6.3.7 Italy market size and forecast
6.3.8 Spain market size and forecast
6.3.9 Rest of Europe market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 India market size and forecast
6.4.5 China market size and forecast
6.4.6 Japan market size and forecast
6.4.7 South Korea market size and forecast
6.4.8 Malaysia market size and forecast
6.4.9 Rest of Asia-Pacific market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil market size and forecast
6.5.5 South Africa market size and forecast
6.5.6 Egypt market size and forecast
6.5.7 Rest of LAMEA market size and forecast

Chapter: 7 COMPANY PROFILES
7.1 Abbott Laboratories

7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategic moves & developments
7.1.5 SWOT analysis

7.2 B. Braun Melsungen AG

7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & developments
7.2.5 SWOT analysis

7.3 Biotronik SE & Co. KG

7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Key strategic moves & developments
7.3.4 SWOT analysis

7.4 Boston Scientific Corporation

7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & developments
7.4.5 SWOT analysis

7.5 C. R. Bard, Inc.

7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & developments
7.5.5 SWOT analysis

7.6 Elixir Medical Corporation

7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Key strategic moves & developments
7.6.4 SWOT analysis

7.7 Medtronic plc

7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & developments
7.7.5 SWOT analysis

7.8 Microport Scientific Corporation

7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & developments
7.8.5 SWOT analysis

7.9 Stentys S.A.

7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & developments
7.9.5 SWOT analysis

7.10 Terumo Corporation

7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategic moves & developments
7.10.5 SWOT analysis
List of Tables:

TABLE 1 WORLD STENTS MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 2 WORLD STENTS MARKET, BY PRODUCT, 20142022 (THOUSAND UNITS)
TABLE 3 CORONARY STENTS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 4 CORONARY STENTS MARKET, BY TYPE, 20142022 (THOUSAND UNITS)
TABLE 5 CORONARY STENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 6 PERIPHERAL STENTS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 7 PERIPHERAL STENTS MARKET, BY TYPE, 20142022 (THOUSAND UNITS)
TABLE 8 PERIPHERAL STENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 9 STENT-RELATED IMPLANTS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 10 STENT-RELATED IMPLANTS MARKET, BY TYPE, 20142022 (THOUSAND UNITS)
TABLE 11 STENT-RELATED IMPLANTS STENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 12 STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 13 STENTS MARKET FOR METALLIC BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 14 STENTS MARKET FOR POLYMERIC BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 15 STENTS MARKET FOR NATURAL BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 16 STENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 NORTH AMERICA: STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 18 NORTH AMERICA: STENTS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 19 EUROPE: STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 20 EUROPE: STENTS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 21 ASIA-PACIFIC: STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 22 ASIA-PACIFIC: STENTS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 23 LAMEA: STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 24 LAMEA: STENTS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 25 ABBOTT - COMPANY SNAPSHOT
TABLE 26 ABBOTT - OPERATING SEGMENTS
TABLE 27 B. BRAUN - COMPANY SNAPSHOT
TABLE 28 B. BRAUN - OPERATING SEGMENTS
TABLE 29 BIOTRONIK - COMPANY SNAPSHOT
TABLE 30 BIOTRONIK - OPERATING SEGMENTS
TABLE 31 BOSTON SCIENTIFIC - COMPANY SNAPSHOT
TABLE 32 BOSTON SCIENTIFIC - PRODUCT CATEGORIES
TABLE 33 BARD - COMPANY SNAPSHOT
TABLE 34 BARD - OPERATING SEGMENTS
TABLE 35 ELIXIR MEDICAL - COMPANY SNAPSHOT
TABLE 36 MEDTRONIC - COMPANY SNAPSHOT
TABLE 37 MEDTRONIC - OPERATING SEGMENTS
TABLE 38 MICROPORT - COMPANY SNAPSHOT
TABLE 39 MICROPORT - PRODUCT CATEGORIES
TABLE 40 STENTYS - COMPANY SNAPSHOT
TABLE 41 TERUMO - COMPANY SNAPSHOT
TABLE 42 TERUMO - PRODUCT CATEGORIES

List of Figures:

FIG. 1 TOP INVESTMENT POCKETS IN WORLD STENTS MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (20142016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 4 PORTERS FIVE FORCES ANALYSIS
FIG. 5 MARKET SHARE ANALYSIS, 2015
FIG. 6 TOP IMPACTING FACTORS: STENTS MARKET
FIG. 7 DRUG-ELUTING STENTS MARKET, 20142022 ($MILLION)
FIG. 8 BARE-METAL CORONARY STENTS MARKET, 20142022 ($MILLION)
FIG. 9 BIOABSORBABLE STENTS MARKET, 20142022 ($MILLION)
FIG. 10 ILIAC STENTS MARKET, 20142022 ($MILLION)
FIG. 11 FEMORAL-POPLITEAL STENTS MARKET, 20142022 ($MILLION)
FIG. 12 RENAL & RELATED STENTS MARKET, 20142022 ($MILLION)
FIG. 13 CAROTID STENTS MARKET, 20142022 ($MILLION)
FIG. 14 SYNTHETIC GRAFTS MARKET, 20142022 ($MILLION)
FIG. 15 VENA CAVA FILTERS MARKET, 20142022 ($MILLION)
FIG. 16 U.S. STENTS MARKET, 20142022 ($MILLION)
FIG. 17 CANADA STENTS MARKET, 20142022 ($MILLION)
FIG. 18 MEXICO STENTS MARKET, 20142022 ($MILLION)
FIG. 19 GERMANY: STENTS MARKET, 20142022 ($MILLION)
FIG. 20 FRANCE: STENTS MARKET, 20142022 ($MILLION)
FIG. 21 U.K.: STENTS MARKET, 20142022 ($MILLION)
FIG. 22 ITALY: STENTS MARKET, 20142022 ($MILLION)
FIG. 23 SPAIN: STENTS MARKET, 20142022 ($MILLION)
FIG. 24 REST OF EUROPE: STENTS MARKET, 20142022 ($MILLION)
FIG. 25 INDIA: STENTS MARKET, 20142022 ($MILLION)
FIG. 26 CHINA: STENTS MARKET, 20142022 ($MILLION)
FIG. 27 JAPAN: STENTS MARKET, 20142022 ($MILLION)
FIG. 28 SOUTH KOREA: STENTS MARKET, 20142022 ($MILLION)
FIG. 29 MALAYSIA: STENTS MARKET, 20142022 ($MILLION)
FIG. 30 REST OF ASIA-PACIFIC STENTS MARKET, 20142022 ($MILLION)
FIG. 31 BRAZIL: STENTS MARKET, 20142022) ($MILLION)
FIG. 32 SOUTH AFRICA: STENTS MARKET, (20142022) ($MILLION)
FIG. 33 EGYPT: STENTS MARKET, 20142022 ($MILLION)
FIG. 34 REST OF LAMEA STENTS MARKET, 20142022 ($MILLION)
FIG. 35 ABBOTT - NET SALES, 20132015 ($MILLION)
FIG. 36 ABBOTT - REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 37 ABBOTT - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 38 ABBOTT - SWOT ANALYSIS
FIG. 39 B. BRAUN - NET SALES, 20132015 ($MILLION)
FIG. 40 B. BRAUN - REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 41 B. BRAUN - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 42 B. BRAUN - SWOT ANALYSIS
FIG. 43 BIOTRONIK - SWOT ANALYSIS
FIG. 44 BOSTON SCIENTIFIC - REVENUE, 20132015 ($MILLION)
FIG. 45 BOSTON SCIENTIFIC - REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 46 BOSTON SCIENTIFIC - CARDIOVASCULAR REVENUE, BY SUBSEGMENT, 2015 (%)
FIG. 47 BOSTON SCIENTIFIC - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 48 BOSTON SCIENTIFIC - SWOT ANALYSIS
FIG. 49 BARD: NET SALES, 20132015 ($MILLION)
FIG. 50 BARD: REVENUE, BY PRODUCT, 2015 (%)
FIG. 51 BARD: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 52 BARD - SWOT ANALYSIS
FIG. 53 ELIXIR MEDICAL - SWOT ANALYSIS
FIG. 54 MEDTRONIC: NET SALES, 20142016 ($MILLION)
FIG. 55 MEDTRONIC - REVENUE, BY SEGMENT, 2016 (%)
FIG. 56 MEDTRONIC - CARDIAC AND VASCULAR GROUP REVENUE, BY SUBSEGMENT, 2016 (%)
FIG. 57 MEDTRONIC - REVENUE, BY GEOGRAPHY, 2016 (%)
FIG. 58 MEDTRONIC - SWOT ANALYSIS
FIG. 59 MICROPORT - NET SALES, 20132015 ($MILLION)
FIG. 60 MICROPORT - REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 61 MICROPORT - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 62 MICROPORT - SWOT ANALYSIS
FIG. 63 STENTYS - NET SALES, 20132015 ($MILLION)
FIG. 64 STENTYS - SWOT ANALYSIS
FIG. 65 TERUMO - NET SALES, 20132015 ($MILLION)
FIG. 66 TERUMO - REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015(%)
FIG. 67 TERUMO - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 68 TERUMO - SWOT ANALYSIS
Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, STENTYS S.A., and Terumo Corporation.
Please select License
Single User Price:$ 4740
Site License Price:$ 5910
Enterprise Price:$ 8250